Haematopoietic stem cell transplantation: Activity in Switzerland compared with surrounding European countries

Swiss Medical Weekly

Volumn 143, Issue , 2013, Pages

  Passweg, Jakob R ^a   Baldomero, Helen ^a   Bargetzi, Mario ^b   Bucher, Christoph ^a   Chalandon, Yves ^c   Duchosal, Michel A ^d   Gratwohl, Alois ^a   Güngör, Tayfun ^e   Hess, Urs ^f   Leibundgut, Kurt ^g   De Faveri, Grazia Nicoloso ^h   Ozsahin, Hulya ^c   Pabst, Thomas ^g   Renner, Christoph ⁱ   Stern, Martin ^a   Stussi, Georg ^j   Schanz, Urs ⁱ  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Universitats Kinderklinik   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h Swiss Blood Stem Cells Registry   (Switzerland)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^j REGIONAL HOSPITAL OF LUGANO   (Switzerland)

more..

Author keywords

Stem cell transplantation in Switzerland; Transplants rates

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; BONE MARROW DEPRESSION; CHRONIC LEUKEMIA; FRANCE; GERMANY; HEALTH CARE SYSTEM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; ITALY; LYMPHOMA; MAJOR CLINICAL STUDY; MYELOABLATIVE CONDITIONING; MYELOMA; NETHERLANDS; NONHODGKIN LYMPHOMA; REDUCED INTENSITY CONDITIONING; SWITZERLAND; UMBILICAL CORD BLOOD; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; DONOR; EUROPE; HEALTH CARE SURVEY; LEUKEMIA; METHODOLOGY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; REGISTER; STATISTICS; UTILIZATION REVIEW;

AUTOIMMUNE DISEASES; EUROPE; HEALTH CARE SURVEYS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; LEUKEMIA; LYMPHOMA; REGISTRIES; SWITZERLAND; TISSUE DONORS;

EID: 84877722635     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2013.13757     Document Type: Article

References (21)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813-26.
2. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G, et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplantation. 2010;45:219-34.
3. Gyurkocza B, Rezvani A, Storb RF. Allogeneic hematopoietic cell transplantation: the state of the art. Expert Rev Hematol. 2010;3(3):285-99. Review.
4. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007;357:1472-5. (Pubitemid 47572632)
5. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007; 369(9577):1947-54. (Pubitemid 46874578)
6. Gluckman E. Ten years of cord blood transplantation: from bench to bedside Br J Haematol. 2009;147(2):192-9.
7. Navarrete C, Contreras M. Cord blood banking: a historical perspective. Br J Haematol. 2009;147(2):236-45.
8. Gyurkocza B, Storb R, Storer BE, et al. Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J Clin Oncol. 2010;28(17):2859-67.
9. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J Niederwieser D, et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematolo-gica. 2010;95:637-43.
10. Blommestein HM, Verelst SG, Huijgens PC, Blijlevens NM, Cornelis-sen JJ, Uyl-de Groot CA. Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study. Ann Hematol. 2012;91(12):1945-52.
11. Leelahavarong P, Chaikledkaew U, Hongeng S, Kasemsup V, Lubell Y, Teerawattananon Y. A cost-utility and budget impact analysis of allo-geneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res. 2010;10:209.
12. Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User's Guide. 2nd ed. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA290200500351 TO3.) AHRQ Publication No. 10-EHC049. Rockville, MD: Agency for Healthcare Research and Quality. September 2010.
13. Ashfaq K, Yahaya I, Hyde C, Andronis L, Barton P, Bayliss S, Chen Y-F. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review. Health Technology Assessment. 2010;54:1.141.
14. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant. 2011;46(2):174-91.
15. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood. 2002;100:2374-86.
16. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, et al. European Group for Blood and Marrow Transplantation (EBMT). The EBMT activity survey: 1990-2010. Bone Marrow Transplant. 2012;47(7):906-23.
17. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, et al. Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16):1617-24.
18. Buhler S, Nunes JM, Nicoloso G, Tiercy JM, Sanchez-Mazas A. The Heterogeneous HLA Genetic Makeup of the Swiss Population. PLoS One. 2012;7(7):e41400. Epub 2012 Jul 25.
19. Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? Bone Marrow Transplant. 2003;31(6):417-21. (Pubitemid 36511805)
20. Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J, et al. Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2011;29(15):1980-6.
21. Fausto R. Loberiza, Jr, Mei-Jie Zhang, Stephanie J. Lee, John P. Klein, Charles F. LeMaistre, Derek S. Serna, et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States Blood. 2005;105:2979-87. (Pubitemid 40446296)